Skip to main content
Ignatius Tang
MD, PharmD, FASN, FAST, FACP

Dr. Tang is the Medical Director of the Kidney and Pancreas Transplant Program and Director of the Living Kidney donor Program at UI Health and an Associate Professor of Clinical Medicine at the University of Illinois at Chicago (UIC). Dr. Tang advocates equal access to transplantation, particularly the socioeconomic disadvantaged transplant populations. He strives to provide comprehensive and patient-individualized care to all kidney and pancreas transplant recipients and living kidney donor candidates.

 

Dr. Tang was born and raised in Hong Kong. He received the Bachelor of Pharmacy (Special Pharmacology) degree from Bradford University School of Pharmacy in England in 1983 and the Doctor of Pharmacy degree from the University of Minnesota in 1986. Dr. Tang completed a 2-year Clinical Pharmacy residency in Nephrology and Transplantation in 1988. He was a Clinical Assistant Professor in Pharmacy Practice at the UIC College of Pharmacy from 1988-1995. Dr. Tang received the Doctor of Medicine degree from Rush Medical College in 1999. He completed the Internal Medicine Residency (1999-2002), Nephrology Fellowship (2002-2004), Clinical Pharmacology Fellowship (2003-2005), and Transplant Nephrology Fellowship (2005-2006) at the University of Chicago. Dr. Tang is board-certified in Internal Medicine, Nephrology, and Clinical Pharmacology.  He joined the Division of Nephrology at UIC in 2006 as a Transplant Physician and an Assistant Professor of Medicine. Dr. Tang became the Medical Director of the Kidney, Pancreas, and Islet Transplant Program at UIC in late 2008. He was the Director of the American Society of Transplantation-accredited Transplant Nephrology Fellowship Program from 2008 to 2016.

 

Dr. Tang’s clinical and research interests include outcomes of kidney transplantation in obese transplant recipients, pancreas and kidney transplant recipients, and other combined organ transplant recipients; long term outcomes of living kidney donors, management of HCV+ and HIV + kidney transplant recipients, antibody-mediated rejection syndromes, atypical hemolytic uremic syndrome in transplant recipients, BK and JC virus allograft nephropathy, post-transplant lymphoproliferative disease, recurrent glomerular disease in kidney transplant, immunopharmacology, pregnancy in transplant recipients, and mineral and bone disorders in kidney transplant recipients.

 

Dr. Tang is fluent in English, Cantonese and Mandarin.